Palmerini, Tullio <br/><br/>
Three, six, or twelve months of dual antiplatelet therapy after DES implantation in patients with or without acute coronary syndromes: an individual patient data pairwise and network meta-analysis of six randomized trials and 11 473 patients.  [electronic resource] 

 -  European heart journal  04 2017 
 - 1034-1043 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Review 
<br/><br/><label>ISSN: </label>1522-9645 
<br/><br/><label>Standard No.: </label>10.1093/eurheartj/ehw627  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Coronary Syndrome--mortality<br/>Analysis of Variance<br/>Aspirin--administration & dosage<br/>Blood Vessel Prosthesis Implantation--methods<br/>Clopidogrel<br/>Coronary Artery Disease--mortality<br/>Death, Sudden, Cardiac--epidemiology<br/>Drug Administration Schedule<br/>Drug Therapy, Combination<br/>Drug-Eluting Stents<br/>Female<br/>Graft Occlusion, Vascular--etiology<br/>Hemorrhage--chemically induced<br/>Humans<br/>Male<br/>Middle Aged<br/>Myocardial Infarction--mortality<br/>Myocardial Revascularization--methods<br/>Platelet Aggregation Inhibitors--administration & dosage<br/>Purinergic P2Y Receptor Antagonists--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Risk Assessment<br/>Stroke--mortality<br/>Ticlopidine--administration & dosage<br/>Treatment Outcome